Contract for the supply of live attenuated intranasal influenza vaccine

A Addendum Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE

Source
Find a Tender
Type
Contract (Goods)
Duration
not specified
Value
___
Sector
HEALTH
Published
14 Jul 2021
Delivery
not specified
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Provision for a contract for the supply of live attenuated intranasal influenza vaccine

Ammendments to Previous Notice

2. Contract conclusion date

Sat Sun Mar 20 21 00:00:00 2021

3. Address of the Contractor

AstraZeneca UK Limited 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, LCB2 CB2 0AA Registration number: 3674842 03674842

4. Explanation

DHSC is procuring these vaccines on the recommendation of the JCVI that this type of vaccine should be offered . There is only one supplier with an exclusive global licence to manufacture and distribute of this type of vaccine which is licensed and approved for use with the applicable Marketing Authorisation in the UK and and, due to the functions of the vaccine, there is no reasonable alternative or substitute, substitute currently licenced for use in the UK. Competition is therefore using absent for technical reasons and the use of the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) and (iii) of the Public Contracts Contract Regulations 2015. 2015 (as amended).

5. Reference number

CM/PHV/14/5433_1 CM/PHV/14/5433

CPV Codes

  • 33651660 - Influenza vaccines

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains